Brief: Medcomtech signs patent license agreement in cancer treatment
Nov 18 (Reuters) - Medcomtech SA MEDC.MC :
* Signs joint ownership and patent license agreement with
scientific institutions over use of silicon particles in cancer
treatment
* Sees to complete pre-clinical trials during 2016
* Says preclinical animal study showed good results
Source text: http://bit.ly/1xAdqWb
Further company coverage: MEDC.MC
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Keywords: MEDCOMTECHSA/BRIEF
Recent news on Medcom Tech SA
See all newsBrief: Medcom Tech H1 Net Result Turns To Profit Of 8.3 Mln Euros YoY
Brief: Medcom Tech FY Net Loss Widens to 9.1 Mln Euros YoY
Brief: Medcom Tech To Run Share Capital Increases Of Up To 4.7 Mln Euros
Brief: Medcom Tech SA Sells Two Units To Minority Shareholders
Brief: Medcom Tech Says Grifols To Invest In Its Diagnostic Unit MedcomAdvance